Your tumor biology matters
DecisionDx-SCC is a genomic test that looks at the tumor biology of your squamous cell carcinoma (SCC) of the skin to better understand the risk of your cancer spreading to other parts of your body.
Individualized risk information: An introduction to DecisionDx-SCC
With DecisionDx-SCC, you and your doctor can make informed decisions about:
DecisionDx-Melanoma is a gene expression profile (GEP) test, which examines the activity of 31 genes in your tumor to provide insights into how your melanoma may behave, potentially impacting your treatment in the following ways:
Discover how DecisionDx-SCC helped a patient avoid radiation therapy
Dr. David Cotter, MD, PhD, Dermatologist Las Vegas Dermatology shares what he finds most valuable about utilizing DecisionDx-SCC to personalize care for his high-risk SCC patients.
Why DecisionDx-SCC?
If you are interested in joining a private online community for patients, caregivers, and clinicians, where those impacted by non-melanoma skin cancer (like squamous cell carcinoma) can ask questions, share experiences, and discover the latest information about treatments, advances, and cutting-edge research, please click the following link to explore and join Skin Cancer Champions